Government Under fire: Cancer Treatment Debates Erupt

Recent debates within the Assembly of French Polynesia have placed the government’s cancer treatment strategies under intense scrutiny. Opposition leaders, and even some within the majority, have voiced serious concerns, accusing the management of endangering public health through alleged actions and inactions related to cancer care.These accusations have prompted a strong response from the French Polynesia Hospital Center (CHPF), the primary healthcare provider in the region.

CHPF Reaffirms Commitment to oncology Patients

In a press release issued Friday, the CHPF sought to reassure the public, emphasizing its role as the pillar of care for cancer patients in French Polynesia. The hospital administration stated unequivocally that oncology care is fully guaranteed, aiming to dispel any doubts arising from the political debates.This statement comes after elected officials cathy Puchon and Hinamoeura Morgant-Cross leveled accusations against Health Minister Cédric mercadal and the government, alleging that their policies were effectively killing people.

The CHPF wishes to reassure its users and remind them that the continuity of oncology care is fully guaranteed.

french Polynesia Hospital Center (CHPF) Press Release

Specific Concerns Raised by Assembly Members

The concerns raised by assembly members were multifaceted.Cathy puchon questioned the government’s decision to withdraw from the agreement with the Gustave-Roussy Institute, a leading European cancer center. She also inquired about the status of the proposed Cancer institute in French polynesia, suggesting that previous administrations had made more progress on the project. The lack of progress on this institute is especially concerning given the rising cancer rates globally and the need for specialized facilities.

Delays and Treatment Suspensions: A Patient’s Perspective

Hinamoeura Morgant-Cross highlighted the impact of these issues on patients, alleging disturbing delays in treatment, the suspension of certain therapies, and the overall uncertainty faced by those awaiting care. She emphasized the need for timely diagnosis, appropriate treatments, and dignified care for Polynesian cancer patients. There have not been any care breaks, actually but there are people who are very very poorly treated. she stated, underscoring the urgency of the situation.

CHPF Defends its Record: Investments and partnerships

In response to the criticisms, the CHPF has defended its record, citing notable investments in cancer care infrastructure. These include the 2015 opening of a dedicated imaging unit with a gamma camera, the 2024 renewal of a particle accelerator in the radiotherapy unit, and plans to install a second accelerator by August 2025. The hospital also highlighted its provision of innovative treatments through its pharmacy.

Furthermore, the CHPF emphasized its collaborative efforts with leading national hospital centers to enhance its medical expertise. These partnerships are crucial for ensuring that patients in French Polynesia have access to the latest advancements in cancer treatment and research.

The CHPF has established partnerships with national benchmark hospital centers in order to to support his medical expertise…The CHPF is the pillar of the management of patients with cancer in French Polynesia.He has continued to strengthen his care offer, based on advanced equipment and multidisciplinary teams fully mobilized.

French Polynesia Hospital Center (CHPF) Press Release

The Path Forward: Ensuring Quality Cancer Care

The debate surrounding cancer care in French Polynesia highlights the critical importance of accessible, high-quality treatment for all citizens. While the CHPF has reaffirmed its commitment to oncology patients, the concerns raised by assembly members warrant further inquiry and action. Continued investment in infrastructure,strategic partnerships,and a focus on patient-centered care will be essential to ensuring the well-being of those affected by cancer in the region. The advancement of the Cancer institute remains a key priority to provide comprehensive and specialized care closer to home.